Drug application
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE (POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE and 1 more)
Drugs@FDA ANDA 090409 · PHARMAZONE
Key facts
| Drug name | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE |
|---|---|
| Active ingredients | POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE |
| Application type | ANDA |
| Application number | 090409 |
| Company | PHARMAZONE |
| Dosage forms | FOR SOLUTION, ORAL |
| Strength | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Apr 2, 2010 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.